Delivery Order SPE2DB22D2211-SPE2DB26FRGVU
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $22,084.22 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Sandostatin LAR Depot 20 mg kits. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,958.92 for Sandostatin LAR Depot 20 mg kits on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price contract with no set-aside designation, representing a competitively awarded delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,639.28 firm fixed-price delivery order for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of September 19, 2025. This competitive, non-set-aside award was issued on September 18, 2025, with performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Sandostatin (octreotide) is a somatostatin analog used primarily to treat acromegaly and neuroendocrine tumors, representing a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $79,481.42 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. Sandostatin LAR...
- The Defense Logistics Agency awarded a delivery order valued at $19,336.91 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. This non-competitive delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery requirement from its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,639.28 on September 19, 2025, for the supply of Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $11,407.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of September 22, 2025. This non-competitive delivery order represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contract vehicle with the DLA. The product, Sandostatin LAR Depot, is a long-acting somatostatin analog used for managing acromegaly and...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $24,528.04 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Sandostatin LAR Depot is a long-acting somatostatin analog used in the treatment of acromegaly and neuroendocrine tumors,...
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...